PET/CT imaging of 18F-FDG was used to assess glucose metabolism. Referring to previous studies [27 (link), 29 (link)], patients fasted for 6–8 h before intravenous injection of 18F-FDG (3.7–4.1 MBq/kg). After 50 min of drug injection, PET/CT imaging was performed with Biograph mCT 64 system (Siemens Healthcare, Germany). Experienced nuclear medicine doctors draw the region of interest (ROI) around the tumor, and automatically calculate and record the maximum and mean standardized uptake value (SUVmax and SUVmean), total lesion glycolysis (TLG) and metabolic tumor volume (MTV) of each ROI through the system.
Free full text: Click here